Indications |
Oral Hyperphosphataemia Adult: Initially 3-4 g daily. Usual range: 6-12 g daily. To control hyperphosphataemia in chronic renal failure Initially 1.334 g (338 mg of calcium). May increase dosage gradually according to serum phosphate conc, provided hypercalcaemia does not occur. |
Warnings / Precautions |
Patients undergoing chronic hemodialysis. Renal impairment, diseases associated with hypercalcaemia such as sarcoidosis & some malignancies. Avoid in patients with calcium renal calculi or a history of renal calculi. |
Adverse Reactions |
GI irritations. Excessive amounts may lead to hypercalcaemia. |
Drug Interactions |
Tetracycline antibiotics, thiazide diuretics, vit D, corticosteroids, bisphosphonates, fluoride, some fluoroquinolones. See Below for More calcium acetate Drug Interactions |
Food Interactions |
Bran. |
Mechanism of Actions |
Sequesters phosphate in the intestine by forming insoluble phosphates that are excreted faecally, thus reducing serum phosphate conc & secondary hyperparathyroidism. Absorption: Mainly from the small intestine. 1,25-Dihydroxycholecalciferol (calcitriol), a metabolite of vit D, enhances absorption. Distribution: Crosses the placenta & distributes into breast milk. Excretion: Excess calcium is mainly excreted renally. Unabsorbed calcium is eliminated in the faeces, secreted in bile & pancreatic juice. Small amounts are lost in the sweat, skin, hair & nails. |
Administration |
Should be taken with food. |
Available As |
|
Calcium Acetate
Post Review about Calcium Acetate Click here to cancel reply.
Calcium Acetate Containing Brands
Calcium Acetate is used in following diseases
Drug - Drug Interactions of Calcium Acetate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.